Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study.

Esophageal cancer starts with subtle symptoms like trouble swallowing, heartburn, and hoarseness, but early detection is ...

Castle Biosciences has signed an agreement to acquire GI health company Previse, which was developed by specialists at Johns Hopkins University School of Medicine in Baltimore. Previse is focused on ...

“We are excited about joining Castle,” said Daniel Lunz, chief executive officer of Previse. “We look forward to the advancements to care we can make together for patients with GI diseases-our ...

Expected to complement Castle's current gastroenterology franchise Adds methylation technology developed at the Johns Hopkins University School of Medicine and additional technologies in development ...

Additionally, an expert physician panel convened by EndoscopyNow will host a product theater on Sunday, May 4, at 2:45 p.m. Pacific Time, titled, “The Time is Now: A Clinical Practice Model to Help ...

The new data shared at DDW 2025 from May 3-6 offers important clinical insights into the evolving role of WATS 3D in Barrett's detection, surveillance and risk assessment. For more information, visit ...

From acid reflux to immune reactions, esophagitis has many causes—learn about its symptoms, types, and the latest treatments ...

Many people haven’t heard of Barrett’s Esophagus, but it’s a serious condition that can be a warning sign for a deadly cancer ...

The 71-year-old was soon diagnosed with gastroesophageal cancer. It was August 2022. The tumor, she said, blocked off a ...

MANILA, Philippines — Alden Richards, Kim Chiu, Julia Barretto, and Barbie Forteza were among the 600 participants who joined the fun run that advocates for early childhood cancer detection.